Table 1 Characteristics of study participants
From: Impact of diabetes on sarcopenia and mortality in patients undergoing hemodialysis
Without sarcopenia | With sarcopenia | p | |
|---|---|---|---|
Number of participants (%) | 184 (60%) | 124 (40%) | |
Gender (male/female) | 116 (38%)/68 (22%) | 69 (22%)/55 (18%) | 0.237 |
Age (y) | 54.4 ± 11.0 | 63.5 ± 11.0 | < 0.001 |
Duration of HD (y) | 6.0 ± 5.6 | 7.1 ± 6.7 | 0.213 |
BMI (kg/m2) | 21.2 ± 2.8 | 19.4 ± 2.5 | < 0.001 |
Diabetes (%) | 50 (27%) | 51 (41%) | 0.015 |
Serum Albumin (g/dL) | 4.1 ± 0.3 | 3.9 ± 0.3 | < 0.001 |
BUN (mg/dL) | 83.5 ± 13.6 | 78.4 ± 12.2 | 0.001 |
Serum Creatinine (mg/dL) | 11.9 ± 2.6 | 9.9 ± 2.2 | < 0.001 |
Phosphate (mg/dL) | 6.2 ± 1.3 | 5.7 ± 1.1 | < 0.001 |
Hemoglobin (g/dL) | 8.9 ± 1.2 | 8.9 ± 1.2 | 0.848 |
HS (kg) | 28.2 ± 9.6 | 15.7 ± 6.3 | < 0.001 |
SMI (kg/m2) | 6.17 ± 1.03 | 5.13 ± 0.72 | < 0.001 |
CRP (mg/dL) | 0.15 (0.10–0.46) | 0.20 (0.12–0.72) | 0.018 |
Kt/V | 1.12 ± 0.24 | 1.20 ± 0.27 | 0.009 |
nPCR (g/kg per day) | 1.05 ± 0.22 | 1.03 ± 0.21 | 0.662 |